Physician profile
Scott M Henry
NPI 1255324539
$1,649.28
in general payments reported to CMS, 2019-2025
15 companies · $83.33 in 2025
The $83.33 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $41.73 · 2021: $1,190 · 2024: $90.90 · 2025: $83.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $174.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,132.65 | 2021 | |
| Bioventus LLC | $95.99 | 2019-2025 | Stimrouter Implantable Kit |
| Axogen | $90.90 | 2024 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Encore Medical, LP | $62.00 | 2019 | |
| Tactile Systems Technology INC | $59.83 | 2019-2021 | |
| Keswick Pharmaceuticals LLC | $53.77 | 2019 | |
| Melinta Therapeutics, LLC | $41.17 | 2019 | |
| Integra Lifesciences Corporation | $18.81 | 2019 | |
| Medela LLC | $15.88 | 2020 | |
| Stryker Corporation | $13.69 | 2021 | |
| Merck Sharp & Dohme LLC | $13.58 | 2019 | |
| Baudax Bio INC. | $13.49 | 2020 | |
| Djo, LLC | $12.94 | 2021 | |
| Smith+Nephew, INC. | $12.36 | 2020 | |
| Osteomed LLC | $12.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.